| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
30,938 |
23,083 |
$2.06M |
| 99051 |
|
4,788 |
4,325 |
$520K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,092 |
5,527 |
$519K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,816 |
8,252 |
$237K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,187 |
5,345 |
$210K |
| 4124F |
|
7,818 |
6,455 |
$153K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,139 |
2,090 |
$142K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,200 |
2,990 |
$136K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,885 |
1,848 |
$133K |
| 96111 |
|
1,138 |
1,122 |
$127K |
| 92586 |
|
1,385 |
1,382 |
$104K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,635 |
1,568 |
$98K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,089 |
1,064 |
$73K |
| 95930 |
|
1,101 |
1,084 |
$73K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
15,623 |
13,588 |
$62K |
| 92588 |
|
1,276 |
1,254 |
$58K |
| 92567 |
|
2,205 |
2,187 |
$29K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,452 |
2,421 |
$29K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,768 |
1,557 |
$29K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,181 |
978 |
$28K |
| 0001A |
|
457 |
435 |
$15K |
| 0002A |
|
398 |
382 |
$15K |
| 99403 |
|
185 |
185 |
$13K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
120 |
116 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
104 |
101 |
$10K |
| 90461 |
|
749 |
707 |
$9K |
| 94667 |
|
360 |
340 |
$8K |
| 99401 |
|
251 |
243 |
$8K |
| 0071A |
|
191 |
188 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
388 |
373 |
$7K |
| 90677 |
|
218 |
216 |
$7K |
| 0072A |
|
159 |
159 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
330 |
307 |
$5K |
| 0003A |
|
131 |
130 |
$5K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
706 |
668 |
$5K |
| G0268 |
Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing |
99 |
97 |
$4K |
| 99173 |
|
308 |
306 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
271 |
246 |
$4K |
| 83655 |
|
237 |
232 |
$3K |
| 90756 |
|
126 |
125 |
$2K |
| 81000 |
|
572 |
570 |
$2K |
| 0073A |
|
48 |
48 |
$2K |
| 85018 |
|
786 |
772 |
$2K |
| 36410 |
|
109 |
108 |
$1K |
| 0011A |
|
48 |
48 |
$1K |
| 0012A |
|
37 |
37 |
$979.38 |
| 99381 |
|
16 |
16 |
$917.52 |
| 99402 |
|
17 |
17 |
$876.69 |
| 90670 |
|
655 |
628 |
$875.27 |
| 90686 |
|
2,098 |
2,049 |
$764.65 |
| 90480 |
|
25 |
24 |
$662.73 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$503.90 |
| 96127 |
|
140 |
138 |
$385.79 |
| 92587 |
|
14 |
14 |
$245.70 |
| 90651 |
|
426 |
411 |
$177.64 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
15 |
14 |
$159.20 |
| 86580 |
|
13 |
13 |
$115.62 |
| 36415 |
Collection of venous blood by venipuncture |
56 |
54 |
$99.00 |
| 90680 |
|
439 |
423 |
$88.28 |
| 90672 |
|
177 |
173 |
$80.64 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
234 |
221 |
$78.35 |
| 90715 |
|
127 |
125 |
$77.04 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
510 |
452 |
$76.60 |
| 90744 |
|
233 |
218 |
$29.90 |
| 36416 |
|
898 |
873 |
$13.50 |
| 90734 |
|
211 |
208 |
$1.00 |
| 90621 |
|
58 |
58 |
$1.00 |
| 91300 |
|
499 |
420 |
$0.01 |
| 90698 |
|
863 |
837 |
$0.00 |
| 99000 |
|
41 |
41 |
$0.00 |
| 91301 |
|
87 |
85 |
$0.00 |
| 90710 |
|
238 |
219 |
$0.00 |
| 90633 |
|
176 |
162 |
$0.00 |
| 99080 |
|
171 |
69 |
$0.00 |
| 90685 |
|
41 |
41 |
$0.00 |